J&J teams with Microsoft for biologics

Johnson & Johnson's IT-savvy pharma R&D group turned to Microsoft Research for help in expanding its small-molecule drug-development platform into biologics development. The attraction: the open-source library of bioinformatics functions within the Microsoft Biology Foundation, part of the Microsoft Biology Initiative.

Like other free, open-source software offerings, MBF provides programmers some prewritten functionality on which they can build, says R&D magazine. That translates into a big head start over an in-house platform development effort; programmers jumped right into developing a greater level of functionality for drug developers.

The J&J group also has distinguished itself as an early adopter of cloud computing.

- here's the story

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.